Clinical Trial

Neurolytic Block Techniques In Abdominal Visceral Cancer Pain

Study acronym: CONCERN
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 3, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The neurolytic blocks of sympathetic chains are commonly used for the treatment of cancer-related pain. This study aims to compare celiac plexus neurolysis and splanchnic nerve neurolysis for the treatment of abdominal visceral pain and its influence on the quality of life of patients with cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-16.
Trial Details
NCT Number NCT06978673
Lead Sponsor Instituto do Cancer do Estado de São Paulo
Conditions Cancer, Malignant Tumors, Abdominal Cancer, Cancer Pain, Visceral Pain, Cancer-related Pain, Pain Management, Celiac Ganglia, Sympathetic Ganglia
Enrollment 64 participants
Start Date 2025-05-30
Primary Completion 2026-05 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-03